Intellectual Property


Charles Andres, Ph.D., RAC, is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. He focuses on patent prosecution, strategic patent counseling, IP due diligence, drug and medical device FDA regulatory counseling, invalidity and non-infringement opinions, life-cycle management, Supreme Court and Federal Circuit amicus briefs, and related business matters.

Charlie has significant experience drafting patent applications, prosecuting patent applications in the U.S. and abroad, and evaluating the claims of issued patents. He has won cases before the Board of Patent Appeals and Interferences by brief and on oral argument. Patents Charlie has obtained have been listed in the Orange Book and asserted against a generic pharmaceutical manufacturer, and he has drafted and filed multiple applications for patent term extension. Companies he has obtained patents for have been sold for a cumulative total of approximately $4 billion.

Charlie has also drafted and prosecuted patents covering three FDA approved drugs. He represented a client at a U.S. Senate HELP Committee full hearing on electronic health records and was part of a team that defended a generic pharmaceutical manufacturer in an Actavis reverse payment enquiry at the Federal Trade Commission.

In addition, Charlie has authored and reviewed numerous freedom-to-operate, invalidity, and non-infringement opinions, including opinions supporting Paragraph IV certification for ANDA filers under the Hatch-Waxman Act. He has advised companies on the use of post-grant U.S. Patent and Trademark Office proceedings to achieve IP goals.

Prior to becoming a patent professional, Charlie spent a decade as a medicinal chemist and early-phase project co-chair at Bristol-Myers Squibb Company, where he won a Presidential Award, among other accolades. He holds Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society.

  • HBX | Harvard Business School, CORe Credential of Readiness, Pass, 2017
  • J.D., Catholic University of America, Columbus School of Law
  • Postdoctoral Fellow with Professor A.I. Meyers, Colorado State University
  • Ph.D., Organic Chemistry, University of Virginia
    Emphases in Computer Aided Design, Synthesis, and Testing of Small Organic Molecules
  • B.S., Chemistry, Hillsdale College
    Cum Laude
  • Member, American Chemical Society
  • Member, American Bar Association
  • Member, Food and Drug Law Institute
  • Member, Regulatory Affairs Professional Society
  • Member, Scientific Advisory Board, Predictive Technology Group
  • Advisor, Technical and Regulatory, Fair Access Medicines
  • Recipient, 2016 and 2019 JD Supra Readers' Choice Award
  • Co-inventor with S. Gerritz, J.A. Tino, and W. Zhai, "Heterocyclic Compounds Useful as Growth Hormone Secretagogues," U.S. Patent No. 7,214,804, 2007
  • Speaker, "FDA Regulatory Issues for Startups," University of San Diego, San Diego, California, June 20, 2019
  • Speaker, "Recent Trends in Licensing, Patents, and FDA," Taylor Wessing Annual Life Sciences Forum, London, June 6, 2019
  • Panelist, "Lessons Learned and Structuring Deals for Success," Chemical Ventures Conference, Delaware Innovation Space, Wilmington, Delaware, April 24, 2019
  • Panelist, "Innovation & Investments: Navigate Policy: What Every Investor and Entrepreneur Should Know," World Health Care Congress, Washington, D.C., March 30, 2019
  • Speaker, "The Ins and Outs," Larger Than Life Science, March 7, 2019
  • "BioTalk with Rich Bendis Podcast," BioHealth Innovation, February 19, 2019
  • Moderator, "How Federal Labs Bring Value to Your Company's Pipeline and Bottom Line," World Vaccine and Immunotherapy Congress, San Diego, November 30, 2018
  • Moderator, "Immuno-oncology Therapeutics: Promises and Challenges," Tedco's Entrepreneur Expo and Stem Cell Symposium, College Park, Maryland, October 30, 2018
  • "Protecting the IP—Options and Alternatives," INOVA PHA Entrepreneurial/Start-Up Lunch and Learn Program, Fairfax, Virginia, October 17, 2018
  • Panelist, "Changes to the Regulatory Landscape in an Innovation Economy... What Is Everyone Really Thinking?" Fairfax, Virginia, October 17, 2018
  • "Life Sciences ROI—Understanding the FDA Approval Process," Keiretsu Forum Mid-Atlantic, Angel Capital Expo, Philadelphia, Pennsylvania, October 16, 2018
  • Moderator, "Combating Drug Resistance," CEO Talks, Columbus Center—Baltimore, September 6, 2018
  • Speaker, "CRISPR IP Landscape and Challenges: Lessons and Suggestions for Researchers and Companies," National Cancer Institute, Rockville, Maryland, June 14, 2018
  • Speaker, "Investment Track: Recent Digital Health Mergers & Acquisition Trends," 15th Annual World Health Care Congress, Washington, D.C., April 29, 2018
  • Keynote Speaker, "Recent Trends in Venture Markets and Financing," Technology Commercialization Office 2018 Start-Up Showcase, The George Washington University, Washington, D.C., April 17, 2018
  • Speaker, "RED Flags in Healthcare/Life Science Due Diligence—What You Should Know," Society of Physician Entrepreneurs, Fairfax, Virginia, April 10, 2018
  • Speaker, "Regulatory Issues for Start-Ups," George Washington University Entrepreneurs Boot Camp, Elliott School of International Affairs, Washington, D.C., March 19, 2018
  • Moderator, "CEO Talk: The Buzz on Immuno-Oncology," BioBuzz, Germantown, Maryland, January 25, 2018
  • Speaker, "Regulatory Issues for Start-Ups," National Cancer Institute Entrepreneur Bootcamp, Rockville, Maryland, October 20, 2017
  • Speaker, "Patents in the Life Sciences," Meeting of the Society for Physician Entrepreneurs, Boston, Massachusetts, June 19, 2017
  • Speaker, "Effective Regulatory Strategies: Tapping into FDA Expedited Review Programs," QB3@953, San Francisco, California, May 4, 2017
  • Panelist, "Strategic Alliances and JVs versus M&A, A New Trend in International Expansion," ABA Section of International Law Spring Meeting, Washington, D.C., April 28, 2017
  • Speaker, "Interview Practice (From the Start-Up Perspective)," The USPTO Biotechnology, Chemical, and Pharmaceutical Partnership Meeting, Alexandria, Virginia, March 16, 2017
  • Co-presenter, "Off-Label Promotion vs. Free Speech," WSGR Medical Device Conference, San Francisco, California, June 24, 2016
  • Speaker, "Off-label Promotion – Minimizing the Risk," FX Conferences, October 16, 2015
  • Bar of the District of Columbia
  • Virginia State Bar
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Patent and Trademark Office

Contact Information

1700 K Street NW
Fifth Floor
Washington, DC 20006
Phone | 202-973-8875

Email | Charles

Areas of Expertise

Print to PDF

JD Supra Readers Choice Top Author 2019